Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

ECG PEER ANALYSIS

Everus Construction Group Inc — metric-by-metric comparison with peers and the industry median

ECGEverus Construction Group Inc

🇺🇸 USA · NYSE · Industrials · Engineering & Construction

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Engineering & Construction

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
ECGIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
ECG+120.8%STN-32.3%ATRL-9.1%SCYR+40.6%SKA-B+27.3%ENKAI+44.7%
Year-to-Date (YTD)
ECG+68.1%STN-22.3%ATRL+2.1%SCYR+28.6%SKA-B+11.3%ENKAI+22.8%
1-Year
Split-adjusted
ECG+120.8%ACA+61.8%MYRG+134.4%TTEK-14.2%GVA+58.6%ROAD-0.3%
Year-to-Date (YTD)
ECG+68.1%ACA+36.9%MYRG+102.6%TTEK-6.7%GVA+28.8%ROAD-0.4%

Key Metric Comparison

P/E

Lower is better
ECG32.96STN23.37ATRL5.63SCYR40.79SKA-B19.21ENKAI15.79Median 30.15

ROE

Higher is better
ECG39.0%STN15.3%ATRL57.1%SCYR9.7%SKA-B9.6%ENKAI10.1%Median 14.6%

Net Margin

Higher is better
ECG5.6%STN6.2%ATRL23.2%SCYR2.0%SKA-B3.3%ENKAI22.0%Median 4.0%

Revenue Growth

Higher is better
ECG29.7%STN30.9%ATRL16.1%SCYR1.7%SKA-B-6.2%ENKAI13.4%Median 13.4%

P/E

Lower is better
ECG32.96ACA32.15MYRG48.91TTEK18.52GVA34.93ROAD47.88Median 30.15

ROE

Higher is better
ECG39.0%ACA8.8%MYRG22.7%TTEK25.6%GVA18.3%ROAD14.2%Median 14.6%

Net Margin

Higher is better
ECG5.6%ACA7.9%MYRG3.7%TTEK9.0%GVA4.0%ROAD3.9%Median 4.0%

Revenue Growth

Higher is better
ECG29.7%ACA8.4%MYRG13.1%TTEK7.9%GVA14.9%ROAD48.8%Median 13.4%

All Metrics

Valuation
MetricECGSTNATRLSCYRSKA-BENKAIInd. Median
P/E32.9623.375.63●40.7919.2115.7930.15
P/B10.723.392.763.941.891.44●3.28
EV/EBITDA21.5112.554.33●8.089.0410.5912.75
P/S1.861.451.310.830.64●3.471.62
Financial Health
MetricECGSTNATRLSCYRSKA-BENKAIInd. Median
Current Ratio1.771.351.061.181.463.36●1.31
Debt/Equity52.8%76.7%24.8%904.3%28.8%1.8%●66.0%
NetDebt/EBITDA0.202.050.055.12-0.10-5.12●1.39
Profitability
MetricECGSTNATRLSCYRSKA-BENKAIInd. Median
Net Margin5.6%6.2%23.2%●2.0%3.3%22.0%4.0%
ROE39.0%15.3%57.1%●9.7%9.6%10.1%14.6%
ROA13.9%6.5%22.0%●0.5%3.5%7.9%4.3%
EBITDA Margin8.7%13.8%30.5%●28.3%7.0%22.1%12.1%
Growth + Dividend
MetricECGSTNATRLSCYRSKA-BENKAIInd. Median
Rev. Growth29.7%30.9%●16.1%1.7%-6.2%13.4%13.4%
NI Growth47.1%27.5%762.5%●-15.8%-7.3%13.5%27.9%
Div. Yield—0.9%0.1%2.0%3.3%4.7%●0.4%
Payout—21.0%0.6%—0.5%73.8%7.0%
Valuation
MetricECGACAMYRGTTEKGVAROADInd. Median
P/E32.9632.1548.9118.52●34.9347.8830.15
P/B10.722.72●9.874.386.266.213.28
EV/EBITDA21.5115.1025.7613.15●14.7319.9612.75
P/S1.862.531.811.661.39●1.871.62
Financial Health
MetricECGACAMYRGTTEKGVAROADInd. Median
Current Ratio1.772.31●1.311.251.091.531.31
Debt/Equity52.8%57.8%8.8%●59.5%135.3%188.4%66.0%
NetDebt/EBITDA0.202.42-0.38●1.292.114.501.39
Profitability
MetricECGACAMYRGTTEKGVAROADInd. Median
Net Margin5.6%7.9%3.7%9.0%●4.0%3.9%4.0%
ROE39.0%●8.8%22.7%25.6%18.3%14.2%14.6%
ROA13.9%●4.5%8.9%10.3%5.5%4.1%4.3%
EBITDA Margin8.7%20.0%●6.9%14.0%11.0%12.1%12.1%
Growth + Dividend
MetricECGACAMYRGTTEKGVAROADInd. Median
Rev. Growth29.7%8.4%13.1%7.9%14.9%48.8%●13.4%
NI Growth47.1%185.0%309.8%●134.2%49.6%106.9%27.9%
Div. Yield—0.1%—0.9%●0.4%—0.4%
Payout—4.4%—15.4%12.3%—7.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ECG

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.